Scheme 1. Preparation of 3-Methylphthalide Precursorsa
a (a) Synthesis and spontaneous intramolecular cyclization of 2-(1-hydroxyethyl)benzonitrile; (b) Chemical synthesis of 2-acetylbenzonitriles 8aꢀf
from the adequate precursor.
noticed. Herein we wish to report a general and straight-
forward chemoenzymatic asymmetric approach for the
synthesis of 3-methylphthalides in enantiopure form
based on the synthesis and bioreduction of substituted
2-acetylbenzonitriles.
aminoacetophenones 7bꢀf in moderate to good yields,11
being lower when electronegative atoms were bonded to
the C-4 position (OMe, F, and Cl, 43ꢀ53%).
Finally the amino ketones were converted into the
desired 2-acetylbenzonitriles by Sandmeyer’s reaction,12
obtaining 8aꢀf in moderate yields, attaining in 70% yield
the methoxy and the chlorinated derivatives 8d,f while the
others, 8a,b,c,e, were isolated in 45ꢀ50% yields.
On the basis of our previous experience in the chemo-
enzymatic synthesis of optically active 2,3-dihydro-
benzofuranes,9 we decided to react 2-bromobenzonitrile
(1) with acetaldehyde in order to develop a synthetic
pathway for the preparation of 2-(1-hydroxyethyl)-
benzonitrile (2a, Scheme 1a). As previously observed by
other research groups,10 the strongly basic reaction me-
dium promoted the spontaneous intramolecular cycliza-
tion of the alcohol. The corresponding imidate 3a was
isolated as the sole product, which slowly evolved to the
complete formation of the phthalide 4a under atmospheric
conditions impeding the use of enzymatic transformations.
This fact was clearly demonstrated by infrared data of the
With 2-acetylbenzonitrile (8a) selected as a model sub-
strate, the first focus was on the development of bioreduc-
tion experiments catalyzed by a panel of commercially
available alcoholdehydrogenasesinTris-HCl buffer work-
ing at their optimum pH (around 7.5), but in all cases
3-hydroxy-3-methyl-2-benzofuran-1(3H)-imine (9a) was
observed as the unique final product. Product formation
may be explained by the instability of the ketone at pH > 7
as outlined in Scheme 2a. First, the formation of the
hemiacetal is highly favored at high pH’s. Then, the
intramolecular cyclization followed by the protonation
of the imide anion led to the formation of the imidate 3a.
At the same time a sample of the racemic alcohol 2a was
searched for analytical purposes, so the chemical reduction
of ketone 8a was attempted with sodium borohydride
(Scheme 2b). Nevertheless, the imidate 3a was obtained
as a unique product instead of the alcohol 2a due to the
instability of the alcohol at basic pH, which lately evolved
to the racemic phthalide 4a under atmospheric conditions
or more rapidly with acidic catalysis.
nonsubstituted imidate CdNH band (around 1680 cmꢀ1
)
and the phthalide CdO band (around 1760 cmꢀ1). IR
spectra are shown in Figure 1a. As the racemic alcohol was
not accessible, an alternative synthetic approach based on
the chemical preparation of ketonitriles 8aꢀf and latter
stereoselective reduction of the carbonyl group with alco-
hol dehydrogenases was designed (Scheme 1b).
2-Acetylbenzonitriles 8aꢀf were prepared from com-
mercially available 20-amino-acetophenone (7a), amino
acids 6b,dꢀf, or 4-methyl-2-nitro-benzoic acid (5c) respec-
tively. Therefore, 4-methyl-2-nitro-benzoic acid was
hydrogenated in the presence of platinum(IV) oxide ob-
taining the amino acid 6c in quantitative yield. Treat-
ment of 6bꢀf with a methyl lithium solution afforded
At this point we moved forward to the use of other
oxidoreductases capable of reacting at neutral or acidic
pH. Among them Baker’s yeast (Saccharomyces cerevisiae)
is possibly one of the most frequently employed micro-
organisms in CdO or CdC bond reductions due to its easy
ꢀ
ꢀ
(9) Mangas-Sanchez, J.; Busto, E.; Gotor-Fernandez, V.; Gotor, V.
Org. Lett. 2010, 12, 3498.
(12) (a) Kushner, S.; Morton, J., II; Boothe, J. H.; Williams, J. H.
J. Am. Chem. Soc. 1953, 75, 1097. (b) Radziejewski, C.; Ghosh, S.;
Kaiser, E. T. Heterocycles 1987, 26, 1227. (c) Vogl, M.; Kratzer, R.;
Nidetzky, B.; Brecker, L. Org. Biomol. Chem. 2011, 9, 5863.
(13) (a) Servi, S. Synthesis 1990, 1. (b) Csuk, R.; Glaenzer, B. I. Chem.
Rev. 1991, 91, 49. (c) Komentani, T.; Yoshii, H.; Matsuno, R. J. Mol.
Catal. B: Enzym. 1996, 1, 45.
(10) (a) Parham, W. E.; Jones, L. D. J. Org. Chem. 1976, 41, 1187. (b)
Kobayashi, K.; Matsumoto, K.; Konishi, H. Heterocycles 2011, 83, 99.
(11) (a) Lee, J. I.; Youn, J. S. Bull. Korean Chem. Soc. 2008, 29, 1853.
(b) Kern, J. C.; Terefenko, E. A.; Fensome, A.; Unwalla, R.; Wrobel, J.;
Cohen, J.; Zhu, Y.; Berrodin, T. J.; Yudt, M. R.; Winneker, R. C.;
Zhang, Z.; Zhang, P. Bioorg. Med. Chem. Lett. 2008, 18, 5015.
Org. Lett., Vol. 14, No. 6, 2012
1445